Key result
Pfizer-BioNTech COVID-19 mRNA vaccination linked to myopericarditis within one week in male adolescent triplets.
Why the study?
Myocarditis and pericarditis have been reported after Pfizer-BioNTech COVID-19 mRNA vaccination, but detailed descriptions in adolescent triplets are limited.
This report highlights the occurrence of myopericarditis in male adolescents shortly after receiving the Pfizer-BioNTech COVID-19 mRNA vaccine.
Answers are grounded in this paper and cite their sources.
Should not change adolescent vaccination practice; hypothesis-generating for genetic susceptibility in familial myopericarditis.
Multiple studies have reported myocarditis and pericarditis after the Pfizer-BioNTech coronavirus disease 2019 messenger ribonucleic acid vaccine. We describe male adolescent triplets who presented with myopericarditis within one week following vaccine administration.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2023) studied this question. Pfizer-BioNTech COVID-19 mRNA vaccination was followed by the development of myopericarditis within one week of administration in male adolescent triplets.
Synapse has enriched 10 related papers. Consider them for comparative context: